{
  "metadata": {
    "input_documents": [
      "medical_student_managing_comorbidities_in_diabetes.pdf",
      "medical_student_long-term_cardiovascular_outcomes.pdf",
      "medical_student_ada_treatment_guidelines_2024.pdf",
      "medical_student_pharmacokinetics_of_insulin_analogs.pdf",
      "medical_student_new_drug_application_sglt2_inhibitors.pdf",
      "medical_student_comparative_study_glp-1_vs_dpp-4.pdf",
      "medical_student_telemedicine_in_chronic_care.pdf",
      "medical_student_pediatric_diabetes_treatment.pdf",
      "medical_student_phase_iii_clinical_trial_metformin_efficacy.pdf",
      "medical_student_patient_lifestyle_intervention_programs.pdf"
    ],
    "persona": "Medical Student",
    "job_to_be_done": "Summarize treatment options for type 2 diabetes from clinical trial reports.",
    "processing_timestamp": "2025-07-21T09:02:00Z"
  },
  "extracted_sections": [
    {
      "document": "medical_student_managing_comorbidities_in_diabetes.pdf",
      "page_number": 4,
      "section_title": "Section 4: Pharmacokinetics of Insulin Analogs",
      "importance_rank": 0.96
    },
    {
      "document": "medical_student_phase_iii_clinical_trial_metformin_efficacy.pdf",
      "page_number": 3,
      "section_title": "Section 3: Long-term Cardiovascular Outcomes",
      "importance_rank": 0.95
    },
    {
      "document": "medical_student_long-term_cardiovascular_outcomes.pdf",
      "page_number": 2,
      "section_title": "Section 2: Comparative Study: GLP-1 vs DPP-4",
      "importance_rank": 0.94
    },
    {
      "document": "medical_student_comparative_study_glp-1_vs_dpp-4.pdf",
      "page_number": 1,
      "section_title": "Section 1: Comparative Study: GLP-1 vs DPP-4",
      "importance_rank": 0.94
    },
    {
      "document": "medical_student_patient_lifestyle_intervention_programs.pdf",
      "page_number": 5,
      "section_title": "Section 5: Telemedicine in Chronic Care",
      "importance_rank": 0.92
    },
    {
      "document": "medical_student_managing_comorbidities_in_diabetes.pdf",
      "page_number": 1,
      "section_title": "Section 1: Pediatric Diabetes Treatment",
      "importance_rank": 0.91
    },
    {
      "document": "medical_student_comparative_study_glp-1_vs_dpp-4.pdf",
      "page_number": 2,
      "section_title": "Section 2: Telemedicine in Chronic Care",
      "importance_rank": 0.88
    },
    {
      "document": "medical_student_phase_iii_clinical_trial_metformin_efficacy.pdf",
      "page_number": 1,
      "section_title": "Section 1: Patient Lifestyle Intervention Programs",
      "importance_rank": 0.81
    },
    {
      "document": "medical_student_phase_iii_clinical_trial_metformin_efficacy.pdf",
      "page_number": 2,
      "section_title": "Section 2: Pharmacokinetics of Insulin Analogs",
      "importance_rank": 0.78
    },
    {
      "document": "medical_student_new_drug_application_sglt2_inhibitors.pdf",
      "page_number": 2,
      "section_title": "Section 2: Comparative Study: GLP-1 vs DPP-4",
      "importance_rank": 0.75
    },
    {
      "document": "medical_student_pediatric_diabetes_treatment.pdf",
      "page_number": 3,
      "section_title": "Section 3: Telemedicine in Chronic Care",
      "importance_rank": 0.74
    },
    {
      "document": "medical_student_patient_lifestyle_intervention_programs.pdf",
      "page_number": 1,
      "section_title": "Section 1: Telemedicine in Chronic Care",
      "importance_rank": 0.74
    },
    {
      "document": "medical_student_ada_treatment_guidelines_2024.pdf",
      "page_number": 2,
      "section_title": "Section 2: New Drug Application: SGLT2 Inhibitors",
      "importance_rank": 0.71
    },
    {
      "document": "medical_student_telemedicine_in_chronic_care.pdf",
      "page_number": 3,
      "section_title": "Section 3: Phase III Clinical Trial: Metformin Efficacy",
      "importance_rank": 0.71
    }
  ],
  "sub_section_analysis": [
    {
      "document": "medical_student_phase_iii_clinical_trial_metformin_efficacy.pdf",
      "page_number": 2,
      "refined_text": "This section provides critical insights into Pharmacokinetics of Insulin Analogs",
      "relevance_score": 0.96
    },
    {
      "document": "medical_student_comparative_study_glp-1_vs_dpp-4.pdf",
      "page_number": 1,
      "refined_text": "This section provides critical insights into Comparative Study",
      "relevance_score": 0.91
    },
    {
      "document": "medical_student_new_drug_application_sglt2_inhibitors.pdf",
      "page_number": 2,
      "refined_text": "This section provides critical insights into Comparative Study",
      "relevance_score": 0.9
    },
    {
      "document": "medical_student_comparative_study_glp-1_vs_dpp-4.pdf",
      "page_number": 2,
      "refined_text": "This section provides critical insights into Telemedicine in Chronic Care",
      "relevance_score": 0.88
    },
    {
      "document": "medical_student_patient_lifestyle_intervention_programs.pdf",
      "page_number": 1,
      "refined_text": "This section provides critical insights into Telemedicine in Chronic Care",
      "relevance_score": 0.84
    },
    {
      "document": "medical_student_managing_comorbidities_in_diabetes.pdf",
      "page_number": 4,
      "refined_text": "This section provides critical insights into Pharmacokinetics of Insulin Analogs",
      "relevance_score": 0.81
    },
    {
      "document": "medical_student_ada_treatment_guidelines_2024.pdf",
      "page_number": 2,
      "refined_text": "This section provides critical insights into New Drug Application",
      "relevance_score": 0.8
    }
  ]
}